SFG
BBIO icon

Steward Financial Group’s BridgeBio Pharma BBIO Stock Holding History

Steward Financial Group’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1K Buy
+50
New +$1.42K ﹤0.01% 1098
2023
Q2 		– Sell
-5
Closed – – 498
2023
Q1 		$0 Hold
5
– – ﹤0.01% 725
2022
Q4 		$0 Buy
+5
New +$48 ﹤0.01% 559
2022
Q3 		– Sell
-7
Closed – – 189
2022
Q2 		$0 Buy
+7
New +$59 ﹤0.01% 983

Other funds holding BBIO

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Steward Financial Group's BBIO Position: Q3 2023 in Review

Steward Financial Group opened a new position in BridgeBio Pharma (BBIO) in Q3 2023: 50 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1098 among its holdings. This is a return to the name: Steward Financial Group previously reported a position in BBIO as recently as Q1 2023.

Steward Financial Group first reported a position in BBIO in Q2 2022 and has held it in 4 quarters since. 221 funds tracked by Wall St. Rank hold BBIO as of Q3 2023.

  • Steward Financial Group held 50 shares of BridgeBio Pharma worth $1K as of Q3 2023.
  • BridgeBio Pharma was a new Steward Financial Group position in Q3 2023.
  • BridgeBio Pharma made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #1098 holding.
  • Steward Financial Group first reported a position in BridgeBio Pharma in Q2 2022 and has held it in 4 quarters since.
  • 221 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.